Sign in
4

Changes in Ownership

ADMA BIOLOGICS, INC. Filed Acc 0001140361-24-039821

Director sold 136,861 shares at $17.27 ($2,363,932)

  • Director acquired 136,861 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Grossman Jerrold B · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-29 Exercise or conversion : show line 1 in the form +118,861 $3.66 $435,031 586,166 D
2024-08-29 Exercise or conversion : show line 2 in the form +9,000 $5.96 $53,640 595,166 D
2024-08-29 Exercise or conversion : show line 3 in the form +9,000 $10.80 $97,200 604,166 D
2024-08-29 Sale : show line 4 in the form −136,861 $17.27 $2,363,932 467,305 D
Open-market sales · 136,861 sh · avg $17.27 · $2,363,932

Table II: Derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-29 Exercise or conversion : show line 5 in the form Common Stock −118,861 $3.66 $435,031 0 D
2024-08-29 Exercise or conversion : show line 6 in the form Common Stock −9,000 $5.96 $53,640 0 D
2024-08-29 Exercise or conversion : show line 7 in the form Common Stock −9,000 $10.80 $97,200 0 D
Loading xslF345X05/form4.xml…